CP-615,003
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
N-(3-fluoro-4-(2-(propylamino)ethoxy)phenyl)-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide
|
|
Identifiers | |
CAS Number | 329016-45-7 |
PubChem | CID: 9820874 |
ChemSpider | 7996623 |
Chemical data | |
Formula | C20H24FN3O3 |
Molecular mass | 373.421 g/mol |
|
|
|
|
(verify) |
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABAA receptors, and was developed by Pfizer as a potential anxiolytic, however poor blood–brain barrier penetration make it primarily useful as a research ligand.[1][2]
References
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Anxiolytics
- Pfizer
- GABAA receptor positive allosteric modulators